Objective: Little is known about biological factors that contribute to purging after normal amounts of food-the central feature of purging disorder (PD). This study comes from a series of nested studies examining ingestive behaviors in bulimic syndromes and specifically evaluated the satiety peptide YY (PYY) and the hunger peptide ghrelin in women with PD (n 5 25), bulimia nervosapurging (BNp) (n 5 26), and controls (n 5 26). Based on distinct subjective responses to a fixed meal in PD (Keel, Wolfe, Liddle, DeYoung, & Jimerson, 2007) , we tested whether postprandial PYY response was significantly greater and ghrelin levels significantly lower in women with PD compared to controls and women with BNp.
PD and controls, who did not differ from each other (Dossat, Bodell, Williams, Eckel, & Keel, 2015; Keel et al., 2007) . While findings validated distinguishing between BNp and PD, they failed to elucidate why individuals with PD purge after consuming normal quantities of food. Importantly, subjective responses to food intake provided clues to disturbances that might be unique to PD. Women with PD endorsed significantly greater postprandial fullness and gastrointestinal distress compared to women with BNp and controls 30 min after meal completion (Keel et al., 2007) . Given the prior study's focus on CCK, this represented the final postmeal assessment, leaving unclear whether biological contributions to purging in PD may be better captured by factors that contribute to satiety rather than satiation.
Although often used interchangeably, satiation and satiety are distinguished by function, underlying physiology, and time course as demonstrated through experimental studies across species (Blundell, 2006) . Specifically, satiation contributes to meal termination while satiety contributes to the delay before the onset of the next meal. Satiation factors, such as CCK and GLP-1, peak 15-20 min postprandially and impact intrameal interval whereas satiety factors, such as peptide YY (PYY), peak 50-90 min postprandially and impact intermeal interval (Steinert et al., 2017) . Given the timing of differences in fullness and gastrointestinal distress (Keel et al., 2007) and effect of experimentally manipulating PYY on nausea (le Roux et al., 2008) , we hypothesized that postprandial PYY response would be exaggerated in PD compared to BNp and controls.
PD participants also reported lower hunger compared to controls and women with BNp pre-and postprandially (Keel et al., 2007) , suggesting that ghrelin might be disrupted in PD. Ghrelin is released from the stomach in fasting states and stimulates hunger and food intake. It peaks after an overnight fast, falls precipitously after a meal, and then increases 2-3 hr postprandially (Steinert et al., 2017) . Experimental studies in animals and humans have demonstrated that the active (acylated) form of ghrelin is responsible for its role in hunger and food intake (Kojima et al., 1999; Kojima & Kangawa, 2010) . Prior comparisons of BN and healthy controls have found higher ghrelin concentrations in BN and have posited that this contributes to excessive food intake during binge episodes (Kojima et al., 2005; Monteleone et al., 2005) . Based on subjective reports of lower hunger in PD (Keel et al., 2007) , we predicted PD participants would have lower active (acylated) ghrelin levels compared to controls and women with BNp. Further, we predicted that women with BNp would have higher ghrelin levels compared to controls.
To test these hypotheses, we extended our gut peptide assessments to 120 min postprandially in PD, BNp, and control participants.
In addition, we explored how gut peptides contributed to subjective responses and whether group differences remained in fullness, hunger, and gastrointestinal distress after accounting for gut peptide responses.
Identification of factors uniquely linked to purging in the absence of binge eating may contribute to the development of novel interventions specific for PD. Such advances would both help those suffering from this disorder and support inclusion of PD as a full-threshold eating disorder in future editions of the DSM and ICD.
| M ET HOD
Data in this article were obtained during a series of probes of ingestive behavior to distinguish factors that contribute to binge eating versus purging behaviors in bulimic syndromes.
| Participants
Women (N 5 77), ages 18 to 45 years, were recruited from the community to participate in a four-visit study that was initiated in Iowa City, IA, and then transferred after 1 year to Tallahassee, FL, where recruitment continued for 4 years. Reflecting this, 13 participants (17%) came from Iowa and 64 (83%) from Florida. This article focuses on women who completed all four study visits, representing 77 (81%) women who initiated the study. There was no significant association between study group and recruitment site (v 2 (2) 5 0.80, p 5 .67) or study completion (v 2 (2) 5 0.27, p 5 .87). Demographic and clinical variables did not differ significantly by recruitment site or study completion (see Supporting Information). Inclusion and exclusion criteria matched those used previously for controls (n 5 26), PD (n 5 25), and BNp (n 5 26) (Keel et al., 2007) , with the following exceptions: (a) we set minimum behavioral symptom frequency at 1/week over the prior 3 months, reflecting DSM-5 BN criteria and PD research criteria (Keel & Striegel-Moore, 2009 ), and (b) PD and BNp were required to use self-induced vomiting and could not have histories of AN.
Inclusion criteria for all participants were body mass index (BMI) between 18.5 and 26.5 kg/m 2 . In addition, participants had to be free of psychotropic medications for 8 weeks as well as medical conditions or treatments that might influence weight or appetite, could not be pregnant or nursing, and could not have a current major depressive episode or current substance dependence due to their potential influence on weight and appetite. With the exception of hormonal contraceptives, which were permitted for contraceptive purposes only, women had to be free of all medications, including over-the-counter medications, for 72 hr before their third and fourth study visits. Thirty-five (45%) women were on hormonal contraceptives, which showed no significant association with study group (v (2) This study was reviewed and approved by the Human Subjects Committee of the IRB at both sites, and participants provided written informed consent prior to study participation. The informed consent document provided a description of all study risks. Participants were paid $75, $50, $100, and $100 across the four visits. Kuyama, & Yamanaka, 1998) . During visit 1, participants completed a brief medical exam, the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) (First, Gibbons, Spitzer, Williams, & Benjamin, 1997) , the Eating Disorders Examination (EDE) (Fairburn & Cooper, 1993) , and self-report questionnaires (see Table 1 ) to establish eligibility and clinical characteristics. Interrater reliability was high in the current study (j 5 .90 for EDE eating disorder diagnosis, r > .97 across EDE subscales, and j > .90 for current and lifetime SCID diagnoses). Visit 2 established a behavioral indicator of satiation through an ad lib meal.
| Procedure
During visits 3 and 4, participants came to the lab between 7:30 and 8:00 a.m. after an overnight fast to complete the fixed meal assessment (Keel et al., 2007 ). An intravenous catheter was placed in their (Stunkard & Messick, 1985) ; BSQ 5 Body Shape Questionnaire (Cooper, Taylor, Cooper, & Fairburn, 1987) ; LOC 5 Loss of Control; ICB 5 Inappropriate Compensatory Behavior.
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| 55 arm, they rested for 5 min and then were given a pill to consume with a small amount of water. The pill was either a placebo or 10 mg of metoclopramide, a medication which influences gastric emptying rate (Saleh & Lebwohl, 1980 (Devlin et al., 1997) . Moreover, 900 kCal is below the threshold for defining an objective binge episode (OBE) because it represents the upper limit of what controls consume in feeding lab studies (Mitchell, Crow, Peterson, Wonderlich, & Crosby, 1998) . Postprandial blood draws occurred 10, 20, 30, 50, 90, and 120 min postprandially.
After each sample, participants completed visual analog scales (VAS) to capture momentary changes in feeling "full," "hungry," "nausea," "stomach ache," "urge to vomit," and "urge to binge." We averaged nausea and stomach ache scores to create a composite gastrointestinal distress score (a 5 .85)
| Gut peptide assessment
Plasma samples for total PYY were collected and stored following instructions for a commercially available radioimmunoassay (RIA) kit (Millipore, St. Charles, MO; PYYT-66HK). Samples collected at the University of Iowa were assayed in the Iowa Clinical Translational Science Core Laboratory. Samples collected at FSU were assayed in a neuroscience laboratory directed by one of the authors (LAE). Plasma was separated from whole blood in a refrigerated centrifuge at 48C and immediately pipetted into chilled tubes (2 mL aliquots) and then transferred to a 2808C freezer until assayed in batches. This procedure was updated when the study was moved to FSU to separate plasma into multiple microcentrifuge tubes (1.5 lL aliquots) prior to freezing. Samples were batched to include all of a participant's samples from study visits 3 and 4 in the same assay and to balance representation of diagnostic groups in each assay. PYY assay sensitivity was 10 pg/mL, and intra-assay and interassay coefficients of variation (CVs) were 5.3% and 7.0%, respectively.
Plasma samples for acylated ghrelin were collected and stored following instructions for a commercially available RIA kit (Millipore; GHRA-88HK), similar to methods described above with two exceptions. First, 150 lL of aprotinin (Sigma #A6279) was added to 3 mL of whole blood in chilled EDTA tubes to maximize stability of the analyte prior to centrifuging. Second, 50 lL of HCl (1.0 N solution) was immediately added to 1 mL of plasma after centrifuging. As with PYY, plasma samples at FSU were separated into 1.5 lL aliquots, and all samples were immediately transferred in dry ice to the 2808C freezer. Due to poor performance of the commercially available RIA for acylated ghrelin at labs in Iowa and Florida, RIAs were discontinued and results are not used in analyses. Back-up samples collected at FSU which had never been thawed (N 5 64 participants; 83% of the total sample) were sent to the Ghrelin Assay Core Laboratory at the University of Virginia for analysis by two-site sandwich assay (Liu et al., 2008) , with sensitivity of 6.7 pg/mL, intra-assay and interassay CVs of 9.1% and 17.8% for total ghrelin. Given that samples were prepared solely for acylated ghrelin assay, we report acylated ghrelin results.
| Data analyses
Multilevel models captured within-subject changes in postprandial gut peptides (Level 1) and whether group (Level 2) predicted levels or moderated changes (Keel et al., 2007; Singer & Willett, 2003) . Bayesian
Information Criteria (BIC) were used to identify the best-fitting model.
Our primary analyses focused on two outcomes: a group 3 time effect for PYY response and a group effect for ghrelin levels. Subsequent analyses of how gut peptides contributed to subjective responses were exploratory and hypothesis generating (Chmura Kraemer, 2017) . Analyses were conducted in IBM SPSS Version 22.
| RE S U L TS

| Clinical characteristics
BNp participants consumed over 3,000 kCal whereas women with PD consumed <500 kcal, on average, during self-reported LOC eating ( 
| Gut peptide responses
Unconditional means and growth models indicated significant variability in PYY levels and within-person change in PYY, respectively (Table   2 ). A full model was fit in which recruitment site, RIA assay kit, and group were included as between-subject effects to determine their influence on the intercept, slope (time), and rate of change (time-squared Figure 1a) . Figure 1b ). (Kojima et al., 2005; Monteleone et al., 2005; Rigamonti et al., 2014) or no significant alteration in postprandial PYY response compared to healthy controls (Devlin et al., 2012) , suggesting that exaggerated PYY response distinguishes PD from BNp. This is the first study to identify a specific biological dysregulation in PD. Future research should examine how these differences might contribute to urge to vomit in the absence of OBEs in PD. Importantly, given that group differences in postprandial gastrointestinal distress were not fully eliminated by controlling for PYY response, future work should expand the range of psychobiological factors evaluated. Findings challenge the ICD proposition that amount of food intake is unimportant among those who purge (Uher & Rutter, 2012) because biologically-based differences may indicate the need for different interventions.
| Gut peptides and subject responses related to purging
Also consistent with one of our hypotheses, ghrelin was elevated in BNp compared to controls. However, contrary to hypotheses, ghrelin was also elevated in PD. Both ghrelin and PYY contributed to hunger, and only BNp evidenced disruption in hunger responses. Previous studies have found higher ghrelin levels in BN compared to controls (Kojima et al., 2005; Monteleone et al., 2005) , similar to our findings, or no significant difference (Devlin et al., 2012) , potentially due to assay of total versus active ghrelin following a smaller (600 kcal vs. 900 kcal) test meal in that study (Devlin et al., 2012) . In this study, women with BNp maintained greater postprandial hunger compared to PD and control participants, consistent with their higher postprandial ghrelin. PD participants did not differ from controls on hunger, potentially reflecting the competing influences of elevated ghrelin and PYY in this group, as both contributed to prediction of hunger.
All groups demonstrated robust postprandial increases in fullness that were predicted by changes in PYY. Given that individual differences in PYY response contributed to individual differences in fullness and group differences in PYY response, the lack of group differences in fullness is somewhat surprising. It is possible that our reliance on a single-item assessment of fullness contributed to lower measurement reliability. In addition, fullness following ingestion of a large meal is influenced by factors beyond PYY, such as CCK, GLP-1, and gastric stretch receptor responses (Strader & Woods, 2005) .
Integrating gut peptide findings across our studies of PD, BNp, and control women suggests a unique pattern of disruptions associated with different symptom configurations of BNp and PD. Compared to controls and a group who purges but does not binge, BNp was associated with blunted CCK and GLP-1 responses (Dossat et al., 2015; Keel et al., 2007) . In addition, compared to controls, BNp demonstrated elevated ghrelin. Future research should examine whether a combination of satiation deficits and sustained hunger in BNp could drive large outof-control binge episodes, which then trigger purging in this group. In contrast, PD was associated with intact CCK (Keel et al., 2007) and GLP-1 function (Dossat et al., 2015) Findings should be interpreted in light of study limitations and strengths. Our sample is less severe with regard to medical and psychological morbidity than patients presenting for treatment due to our exclusion criteria. We excluded children, adults over the age of 45, men, individuals outside of a healthy weight range, and with medical or other psychological conditions that could influence results, which limit generalizability of findings. Our sample was not completely medication free. We provided no specific instructions regarding use of laxatives or diuretics on days prior to gut peptide assessment and do not know what effects such use may have. We permitted use of hormonal contraceptives, and we did not control for menstrual cycle day in analyses, which should be considered in future studies. The test meal was not adjusted for BMI; however, participants were within a healthy weight range, and groups did not differ on BMI. Moreover, the test meal we employed allowed us to replicate and extend findings from prior studies using the same test meal (Devlin et al., 1997; Keel et al., 2007) .
